top of page

Insights & Updates


Four Reasons Antibody Programs Fail Before They Reach Patients
The most successful translational strategies increasingly focus on generating human-relevant evidence earlier, when development teams still have the opportunity to refine candidate selection, optimize trial design, and reduce uncertainty before major investments are made.
Featured
Search


The Validation Gauntlet: Multi-Modal Framework for Fit-for-Purpose IHC
A detailed examination of the technical pillars of assay validation, from tissue integrity screening and antibody selection to antibody validation with ISH and isPLA
evadanielson55
Apr 285 min read
bottom of page
